Study of the Safety and Pharmacokinetics of KSP-1007 Alone and Coadministered With Meropenem in Healthy Subjects
Clinical trial NCT05226923 · COMPLETED
Trial details
- NCT number
- NCT05226923
- Sponsor
- Sumitovant Biopharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-12
- Primary completion
- 2022-10-01
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.